Literature DB >> 26264690

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.

Xinglei Chai1, Susan Domchek1, Noah Kauff1, Timothy Rebbeck2, Jinbo Chen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26264690      PMCID： PMC4836813          DOI： 10.1093/jnci/djv217

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Graphical representation of survival curves associated with a binary non-reversible time dependent covariate.

Authors:  E J Feuer; B F Hankey; J J Gaynor; M N Wesley; S G Baker; J S Meyer
Journal:  Stat Med       Date:  1992-02-28       Impact factor: 2.373

2.  Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.

Authors:  B A M Heemskerk-Gerritsen; C Seynaeve; C J van Asperen; M G E M Ausems; J M Collée; H C van Doorn; E B Gomez Garcia; C M Kets; F E van Leeuwen; H E J Meijers-Heijboer; M J E Mourits; T A M van Os; H F A Vasen; S Verhoef; M A Rookus; M J Hooning
Journal:  J Natl Cancer Inst       Date:  2015-03-18       Impact factor: 13.506

3.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Authors:  Nasim Mavaddat; Susan Peock; Debra Frost; Steve Ellis; Radka Platte; Elena Fineberg; D Gareth Evans; Louise Izatt; Rosalind A Eeles; Julian Adlard; Rosemarie Davidson; Diana Eccles; Trevor Cole; Jackie Cook; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Shirley Hodgson; Lisa Walker; Mary E Porteous; Patrick J Morrison; Lucy E Side; M John Kennedy; Catherine Houghton; Alan Donaldson; Mark T Rogers; Huw Dorkins; Zosia Miedzybrodzka; Helen Gregory; Jacqueline Eason; Julian Barwell; Emma McCann; Alex Murray; Antonis C Antoniou; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2013-04-29       Impact factor: 13.506

4.  Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.

Authors:  Susan M Domchek; Timothy R Rebbeck
Journal:  LDI Issue Brief       Date:  2010 Oct-Nov

Review 5.  Bias in intervention studies that enroll patients from high-risk clinics.

Authors:  Sholom Wacholder
Journal:  J Natl Cancer Inst       Date:  2004-08-18       Impact factor: 13.506

6.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544
  6 in total
  3 in total

1.  Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China.

Authors:  Li Sun; Bin Cui; Xia Wei; Zia Sadique; Li Yang; Ranjit Manchanda; Rosa Legood
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

2.  Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).

Authors:  Phuong L Mai; Austin Miller; Mitchell H Gail; Steven Skates; Karen Lu; Mark E Sherman; Olga B Ioffe; Gustavo Rodriguez; David E Cohn; John Boggess; Thomas Rutherford; Noah D Kauff; Janet S Rader; Kelly-Anne Phillips; Paul A DiSilvestro; Alexander B Olawaiye; Mildred R Ridgway; Mark H Greene; Marion Piedmonte; Joan L Walker
Journal:  JNCI Cancer Spectr       Date:  2019-10-10

3.  A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.

Authors:  Li Sun; Adam Brentnall; Shreeya Patel; Diana S M Buist; Erin J A Bowles; D Gareth R Evans; Diana Eccles; John Hopper; Shuai Li; Melissa Southey; Stephen Duffy; Jack Cuzick; Isabel Dos Santos Silva; Alec Miners; Zia Sadique; Li Yang; Rosa Legood; Ranjit Manchanda
Journal:  JAMA Oncol       Date:  2019-10-03       Impact factor: 31.777
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.